About: Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Both second-line treatments, a combination of carboplatin and vinblastine and a monotherapy with docetaxel, showed modest activity at subtoxic doses in patients with HRPC.~
  • Both second-line treatments, a combination of carboplatin and vinblastine and a monotherapy with docetaxel, showed modest activity at subtoxic doses in patients with HRPC.~ (en)
  • Oba režimy 2. linie, jak kombinace karboplatiny a vinblastinu, tak monoterapie docetaxelem, vykazovaly průměrnou účinnost při subtoxických dávkách u pacientů s HRPC.~ (cs)
Title
  • Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?
  • Je rozumné uvažovat o chemoterapii 2. linie u pacientů s hormonálně refrakterním karcinomem prostaty? (cs)
  • Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer? (en)
skos:prefLabel
  • Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?
  • Je rozumné uvažovat o chemoterapii 2. linie u pacientů s hormonálně refrakterním karcinomem prostaty? (cs)
  • Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer? (en)
skos:notation
  • RIV/00179906:_____/05:00001858!RIV06-MZ0-00179906
http://linked.open.../vavai/riv/strany
  • 1077-1081
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • Z(MZ0FNHK2005)
http://linked.open...iv/cisloPeriodika
  • 4
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 525702
http://linked.open...ai/riv/idVysledku
  • RIV/00179906:_____/05:00001858
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • hormone-refractory prostate cancer; second-line chemotherapy; docetaxel; carboplatin; vinblastine (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • GR - Řecká republika
http://linked.open...ontrolniKodProRIV
  • [5B78E69755B1]
http://linked.open...i/riv/nazevZdroje
  • Oncology Reports
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 14
http://linked.open...iv/tvurceVysledku
  • Doležal, Jiří
  • Morávek, Petr
  • Odrážka, Karel
  • Petera, Jiří
  • Vošmik, Milan
  • Šimáková, Eva
  • Prošvic, Petr
  • Zoul, Zdeněk
  • Doležel, Martin
  • Vaculíková, Miloslava
http://linked.open...n/vavai/riv/zamer
issn
  • 1021-335X
number of pages
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software